Pair rosacea care with a full look inside
Membership includes inflammation, hormone, and metabolic markers in a single draw.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
At a glance
- Topical ivermectin 1% cream (sold as Soolantra) is a prescription treatment for inflammatory, papulopustular rosacea.
- It works in two ways at once, reducing Demodex mites on the skin and lowering inflammation.
- In head-to-head comparisons, it is often the most effective topical option, including against metronidazole.
- It is applied once a day and stays well tolerated with long-term use.
- Evidence strength: Strong, backed by phase 3 randomized trials and systematic reviews.
What is topical ivermectin?
Topical ivermectin is an antiparasitic drug formulated as a 1% facial cream for rosacea. What sets it apart is a dual action. It lowers numbers of Demodex mites, tiny organisms that live in facial follicles and are more abundant in rosacea skin, and it also calms inflammation directly. A systematic review of ivermectin for papulopustular rosacea described this combination of mite-clearing and anti-inflammatory activity as a more cause-directed approach than older treatments.
What skin type is topical ivermectin best for?
It fits people with inflammatory rosacea, meaning rosacea-prone skin that produces papules and pustules rather than only redness. The cream base is reasonably rich, so it tends to be comfortable on normal to dry skin, and it can be a good choice for those who found other rosacea creams drying. It is not designed for plain oily skin or common acne, and it is not a redness-only treatment.
What does topical ivermectin treat?
Topical ivermectin treats the inflammatory bumps and pustules of papulopustular rosacea and reduces the surrounding redness as lesions clear. In a GRADE systematic review, topical ivermectin reached high-certainty evidence for reducing papules and pustules, placing it among the strongest topical choices. A separate review found it more effective than metronidazole at 12 weeks, though relapse after stopping was common with both drugs.
How do you know if topical ivermectin can help your skin?
A clinician's diagnosis of papulopustular rosacea is the main guide, especially when bumps and pustules on the central face keep returning. It is often considered when rosacea is moderate to severe, or when another topical has not controlled the bumps well enough. Because mite burden and inflammation both play a part, people whose rosacea runs inflammatory tend to be the best candidates. A prescriber can confirm the diagnosis and rule out acne or other rashes.
How do you use topical ivermectin?
Apply a small, pea-sized amount spread as a thin layer over the whole face once a day, avoiding the eyes, lips, and the inside of the nose. Use it on clean, dry skin and let it absorb before other products. Improvement builds over weeks, and in long-term investigator-blinded extension studies it stayed effective and well tolerated for up to a year of continued use, so it is often continued as maintenance.
What are the potential side effects of topical ivermectin?
Side effects are usually mild and limited to where it is applied, such as a burning or stinging feeling, dry skin, itching, or temporary redness. Some people notice a brief flare early in treatment that then settles. Serious reactions are rare with the cream. If stinging is bothersome, applying to fully dry skin and pairing it with a bland moisturizer can help. This is general information rather than medical advice, so follow your prescriber's guidance.
Evidence strength
Strong: Topical ivermectin has been tested in large phase 3 randomized controlled trials and summarized in systematic reviews that place it among the most effective topicals for papulopustular rosacea, with high-certainty evidence for clearing bumps. The real-world caveat is that it manages rather than cures rosacea, and relapse within several months of stopping is common, so ongoing use is usually needed to keep results.
References
- Ebbelaar CCF, Venema AW, Van Dijk MR. Topical Ivermectin in the Treatment of Papulopustular Rosacea: A Systematic Review of Evidence and Clinical Guideline Recommendations. Dermatology and Therapy. 2018;8(3):379-387. doi:10.1007/s13555-018-0249-y
- van Zuuren EJ, Fedorowicz Z, Tan J, et al. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments. British Journal of Dermatology. 2019;181(1):65-79. doi:10.1111/bjd.17590















